Option Care Health, Inc. (OPCH) Stock Price & Analysis
Option Care Health, Inc. (OPCH) rose 2.75% to USD 21.66 as of July 25, 2026 at 03:03 UTC, according to Nexqual real-time market data.
OPCH last closed at USD 21.08; the session ranged USD 20.85–21.68 on volume of 1,571,058 shares. Market capitalization is $3.40B, with a 52-week range of USD 18.01–36.8 (NMS). Source: Nexqual, July 25, 2026 at 03:03 UTC.
Key Statistics (as of July 25, 2026 at 03:03 UTC)
| Price | USD 21.66 |
|---|---|
| Change | ▲ 2.75% (up) |
| Previous Close | USD 21.08 |
| Open | USD 21.08 |
| Day Range | USD 20.85 – 21.68 |
| 52-Week Range | USD 18.01 – 36.8 |
| Volume | 1,571,058 shares |
| Market Cap | $3.40B |
| Exchange | NMS |
Technical Analysis (OPCH)
Nexqual's technical model rates OPCH "NEUTRAL" based on 3 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 03:03 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 54.01 (neutral) |
| vs SMA50 | Above (USD 21.21) |
| MACD | -0.01 (negative) |
Analyst Ratings (OPCH)
Wall Street analysts rate OPCH "Buy" based on 12 analysts, with a mean price target of USD 28.08 (range USD 22–39), per Nexqual as of July 25, 2026 at 03:03 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 12 |
| Mean Target | USD 28.08 |
| High Target | USD 39 |
| Low Target | USD 22 |
| Buy / Hold / Sell | 9 / 4 / 0 |
Earnings (OPCH)
| Next Earnings Date | 2026-07-29 |
|---|---|
| EPS Estimate | USD 0.43 |
| Revenue Estimate | $1.42B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.4 vs est 0.37 ▲ beat |
| 2025-12-31 | USD 0.46 vs est 0.47 ▼ miss |
| 2025-09-30 | USD 0.45 vs est 0.43 ▲ beat |
| 2025-06-30 | USD 0.41 vs est 0.4 ▲ beat |
Source: Nexqual, July 25, 2026 at 03:03 UTC.
Financials & Fundamentals (OPCH)
| Total Revenue | $5.67B |
|---|---|
| Revenue Growth (YoY) | +1.30% |
| Gross Margin | +19.18% |
| Operating Margin | +5.37% |
| Profit Margin | +3.64% |
| ROE | +15.26% |
| Debt / Equity | 94.01 |
| Current Ratio | 1.64 |
| Total Cash | $181.85M |
| Total Debt | $1.27B |
| Free Cash Flow | $168.69M |
Source: Nexqual, July 25, 2026 at 03:03 UTC.
Financial Health Score (OPCH)
Nexqual rates Option Care Health, Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 03:03 UTC.
| Growth | Solid — Revenue +13% YoY (annual) |
|---|---|
| Profitability | Mixed — Gross margin 19%, operating 5% |
| Balance Sheet | Mixed — $182M cash vs $1.27B debt |
| Cash Flow | Mixed — FCF $169M, slim 3.0% margin |
| Efficiency | Solid — ROE 15%, ROA 6.2% |
Ownership (OPCH)
| Insider Ownership | +1.20% |
|---|---|
| Institutional Ownership | +109.73% |
| Shares Outstanding | 157.03M |
| Float | 145.91M |
| Short % of Float | +11.54% |
Source: Nexqual, July 25, 2026 at 03:03 UTC.
Leadership (OPCH)
Option Care Health, Inc. is led by John Charles Rademacher (age 58), CEO, President & Director, per Nexqual as of July 25, 2026 at 03:03 UTC.
| CEO, President & Director | John Charles Rademacher (age 58) |
|---|---|
| Executive VP & CFO | Meenal Anil Sethna (age 55) |
| Chief Operating Officer | Luke Whitworth (age 44) |
| Chief Technology Officer | Brett Michalak |
Major Backers & Investors (OPCH)
Notable institutional backers of Option Care Health, Inc. include Wellington Management, Durable Capital Partners Lp, Fuller & Thaler Asset Management Inc., according to Nexqual as of July 25, 2026 at 03:03 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Wellington Management | 7.58% |
| Durable Capital Partners Lp | 5.73% |
| Fuller & Thaler Asset Management Inc. | 4.54% |
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Equity Fund | 4.33% |
| FMR, LLC | 4.09% |
| Arrowstreet Capital, Limited Partnership | 2.7% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 23.4% |
| BlackRock | 18.53% |
| State Street | 3.74% |
| Geode Capital | 2.71% |
Source: Nexqual, July 25, 2026 at 03:03 UTC.
From Option Care Health, Inc.'s Latest SEC 10-K Filing (filed 2026-02-24)
Key Strengths & Strategy (as disclosed to the SEC)
- Option Care Health, Inc. offers home and alternate site infusion services in the United States.
- It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services.
- The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SGRY | Surgery Partners, Inc. | USD 15.73 | ▲ 3.83% |
| EHC | Encompass Health Corporation | USD 112.89 | ▲ 1.68% |
| PRVA | Privia Health Group, Inc. | USD 25.5 | ▲ 0.51% |
| PNTG | The Pennant Group, Inc. | USD 41.16 | ▲ 1.76% |
| LIVN | LivaNova PLC | USD 78.19 | ▼ 0.1% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:03 UTC. This page is informational and not investment advice.